openPR Logo
Press release

Fibrosarcoma Market Expected to Secure Notable Revenue Share during 2017 to 2026 | Key Players are Celon Laboratories Ltd., Bristol-Myers Squibb Compan, etc.

08-13-2019 10:57 AM CET | Health & Medicine

Press release from: Fact.MR

Fibrosarcoma Market Expected to Secure Notable Revenue Share

In order to dissert the market scenario prevailing across the fibrosarcoma market sector, Fact.MR has evenly presented a comprehensive analysis report on fibrosarcoma market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the fibrosarcoma market in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable.

Request for a Free Sample Report of Concerned Market - https://www.factmr.com/connectus/sample?flag=S&rep_id=353

Fibrosarcoma is cancer, which is a part of larger collection of cancers known as sarcomas. Fibrosarcoma is generally treated with the help of chemotherapy. Meanwhile, some fibrosarcoma is not treatable with chemotherapy, especially in the case where cancer has spread to the parts like liver. In order to treat such type of cancers, researchers are focusing on developing targeted therapies. These targeted therapies attempt to capitalize on the biological characteristic of a cancer cell to eradicate the tumor. This is the factor that will make targeted therapy more effective than the traditional treatments. There are two important reasons for the development of targeted therapy. One is that it targets only cancer cells and kills it, while normal cells can spread. Second is that it provides effective treatment with minimum side-effects. Pharmaceutical companies are also focusing on research and development of drugs that can be effective in the treatment of fibrosarcoma and other types of sarcomas.

As per the new report by Fact.MR, the global fibrosarcoma market is likely to witness steady growth between 2017 and 2026. The market is estimated to reach US$ 442.4 million revenue by 2026 end. Owing to the increasing prevalence of cancer, the use of cancer treatment drugs along with the radiotherapy and chemotherapy is witnessing a significant growth. However, increasing use of radiotherapy to treat various cancers is resulting in the fibrosarcoma. This is leading to the growth in the research activities to find out an effective way to treat cancer.

Chemotherapy to Emerge as the Highly Preferred Treatment Type

Among various treatment types such as radiation therapy, surgery, and others, chemotherapy is likely to emerge as the highly preferred treatment for fibrosarcoma. Chemotherapy is estimated to surpass US$ 100 million by 2026 end. A chemotherapy is done before surgery in case if the cancer is large but has not spread. This helps in reducing fibrosarcoma and also helps in avoiding much surgery.

Hospitals to Gain Maximum Revenue Share

Hospitals are likely to witness the highest growth between 2017 and 2026.  Hospitals are estimated to gain nearly two-fifth of the revenue share by 2017 end. Hospitals are also estimated to create an incremental opportunity of nearly US$ 100 million between 2017 and 2026. Increasing investment by governments in various countries towards the development of healthcare infrastructure is contributing towards the significant growth of the hospitals with technically advanced treatments.

Hospital Pharmacy to Emerge as One of the Largest Distributors

Hospital pharmacy is likely to be one of the largest distribution channels in the global fibrosarcoma market during 2017-2026. Hospital pharmacy is projected to bring in nearly US$ 200 million revenue towards 2026 end. Hospital pharmacy in many countries is emerging as the biggest distributors of the drugs used in treating cancer. Moreover, availability of various drugs and government support are also resulting in the growth of the hospital pharmacy as a distribution channel. 

Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=353

Competition Tracking

The report offers information on the key companies that are likely to play an active role in the expansion of global fibrosarcoma market through 2026, which include Cadila Pharmaceuticals Limited, Celon Laboratories Limited, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Novartis AG, Baxter International Inc., Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibrosarcoma Market Expected to Secure Notable Revenue Share during 2017 to 2026 | Key Players are Celon Laboratories Ltd., Bristol-Myers Squibb Compan, etc. here

News-ID: 1821674 • Views: 295

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Fact.MR
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases


More Releases for Hospital

Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Hospital Logistics Robots Market 2018
Hospital logistics robots comprise autonomous guided vehicles (AGVs) and mobile robot platforms. These are used for managing the flow of goods such as laboratory samples, food, pharmaceuticals, environmental waste, and laundry inside hospital premises. Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-hospital-logistics-robots-2018-2023-863 This report focuses on the Hospital Logistics Robots in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based
Hospital Privacy Screens
Business NEWS 2018 : Hospital Privacy screens are designed to provide privacy and protection and create more pleasant environment for patients in private clinics, hospitals, nursing homes, and specialty care centers. It is one of the best alternatives to the curtains, which is the source of infection that cannot be cleaned regularly, as its hard surface can be wiped and disinfected regularly, thus eliminating the need to remove, launder, and
Lotus Eye Care Hospital
Lotus Eye Care Hospital Lotus Eye Care Hospital- Company Profile & Financial Analysis” contains in depth information and data about the company and its operations. You will find information on the business structure, areas of operation, products and services offered by the company. It also comprises SWOT analysis, key ratios, historical financial data and insider’s view on financial stability and industrial ranking with financial forecasts for two- year period. This report is
Neuromed hospital grows
Mitsubishi Electric Hydronics & IT Cooling Systems, with its brand Climaveneta, provided air conditioning units to the new clinic belonging to Neuromed Institute in Italy, after having successfully supplied other units to the same hospital in the past years. Five years after laying the first stone, the new clinic of the Neurology Institute was inaugurated on October 27th. The Hospital boasts a high degree of specialization in Neurosurgery, Neurology, and all
The Hospital undergoing surgery
Gustavo Frickle Hospital is a new 92,000 sqm building in Viña del mar, Chile. This modern 11-storey structure with 554 rooms, clinical wards and an heliport, will be inaugurated in March 2017. Providing patients and medical personnel with ideal temperature and humidity conditions as well as huge amount of sanitary hot water, achieving these with reduced acoustic emissions and highest efficiency, are the key challenges for the HVAC system of the